The leading source for credible citizen reporting

Report Your News
Take the tour...

This event is older than two months and is no longer active. Some links older than two months could be broken.

Report Your News

Click here to post a new related report

Eli Lilly Cancer Drug Shows 'significant" Benefit

Source: Fox News
Indianapolis : IN : USA | 2 months ago  
Views: 1
Phase III clinical trial of its lung cancer drug Alimta showed a significant survival benefit in patients with advanced non-small cell lung cancer.
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: Androscoggin News | 2 months ago
    Adolor Corp. acquired the worldwide rights Monday to OpRA III, a clinical-stage experimental drug with multiple potential uses, from Eli Lilly and Co...LLY) of Indianapolis $2 million upfront, royalties on net sales of any approved product, and up to...
  • News Source: Uinta County News | 2 months ago
    All Briefing.com news Micromet reports interim data from phase 1 study of BiTE antibody MT110 for the treatment of solid tumors Co presented first interim data from a phase 1 dose-escalation clinical study for BiTE antibody MT110, the first T-cell...
  • News Source: Uinta County News | 2 months ago
    All Briefing.com news Celsion announces that Data Safety Monitoring Board recommends continuation of it's Phase III ThermoDox study for primary liver cancer Co announces the Data Safety Monitoring Board has reviewed the safety data from the first...
  • News Source: The Noblesville Ledger | 2 months ago
    Eli Lilly and Co.'s OpRA III, an experimental medicine to restore bowel function in people taking narcotic painkillers. Exton, Pa.-based Adolor, the maker of constipation drug Entereg, will pay $2 million upfront to Indianapolis-based drug maker...
  • News Source: Androscoggin News | 2 months ago
    Cancer patients who receive chemotherapy are more likely to develop blood clots than other people, but now a new study says a blood-thinning drug could cut the risk in half. Besides posing a significant risk of problems in the heart, brain and lungs,...
  • News Source: Xtra News | 2 months ago
    Cancer patients whose tumors are targeted with heat treatment as well as chemotherapy are more likely to stay alive and cancer-free for longer than those who receive only chemotherapy, researchers said on Tuesday. The finding suggests it may be...
Most Popular Reports

Related Allvoices Reports

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.